日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

针对接受酪氨酸激酶抑制剂治疗的慢性粒细胞白血病患者,建立了一个预测治疗失败的模型。

Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Yanli; Xu, Na; Gale, Robert Peter; Li, Weiming; Liu, Xiaoli; Zhu, Huanling; Pan, Ling; Yang, Yunfan; Lin, Hai; Du, Xin; Liang, Rong; Chen, Chunyan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Zhang, Yanqing; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Li, Fei; Yang, Wei; Meng, Li; Han, Yanqiu; Lin, Li'e; Zhao, Zhenyu; Tu, Chuanqing; Zheng, Caifeng; Bai, Yanliang; Zhou, Zeping; Chen, Suning; Qiu, Huiying; Yang, Lijie; Sun, Xiuli; Sun, Hui; Zhou, Li; Liu, Zelin; Wang, Danyu; Guo, Jianxin; Pang, Liping; Zeng, Qingshu; Suo, Xiaohui; Zhang, Weihua; Zheng, Yuanjun; Huang, Xiaojun; Jiang, Qian

De-escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open-label, prospective trial in China

慢性粒细胞白血病患者酪氨酸激酶抑制剂减量或停药:一项在中国开展的多中心、开放标签、前瞻性试验

Luo, Jie; Du, Xin; Lou, Jin; Wu, Jianwei; Ma, Liping; Huang, Jixian; Wang, Liangtuo; Tu, Chuanqing; Liu, Zelin; Chen, Liya; Tan, Yaxian; Luo, Dongmei; Liang, Hanyin; Yin, Changxin; Cao, Rui; Zhou, Xuan; Liu, Qifa; Liu, Xiaoli; Xu, Na

SDF-1α Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients with Immune Thrombocytopenia.

SDF-1α促进间充质干细胞诱导免疫性血小板减少症患者产生调节性B细胞

Chen Zhe, Zhou Shufen, Li Jianyun, Li Hui, Huang Can, Guo Qin, Zhang Tiantian, Yang Bingya, Tu Chuanqing, Guo Chengshan

Chronic myeloid leukemia patients and treatment-free remission attitudes: a multicenter survey

慢性粒细胞白血病患者对无治疗缓解的态度:一项多中心调查

Lou, Jin; Huang, Junjie; Wang, Zitong; Wen, Bingbing; Tu, Chuanqing; Huang, Wangxiang; Zhai, Zhimin; Du, Xin

[Myeloid sarcoma with acute promyelocytic leukemia:two cases report]

【髓系肉瘤合并急性早幼粒细胞白血病:两例报告】

Li, Jianyun; Tu, Chuanqing; Wang, Dianwen; Huang, Can; Zhang, Xuyan